{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:59:11Z","timestamp":1785315551296,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sanofi"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11136-026-04251-7","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T21:02:46Z","timestamp":1777842166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experiences and treatment perspectives of adolescents and young adults with achondroplasia and caregivers: a qualitative interview study"],"prefix":"10.1007","volume":"35","author":[{"given":"Joshua","family":"Maher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela S.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemre","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Quaife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bascle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"issue":"10","key":"4251_CR1","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/ajmg.a.61787","volume":"182","author":"PK Foreman","year":"2020","unstructured":"Foreman, P. K., van Kessel, F., van Hoorn, R., van den Bosch, J., Shediac, R., & Landis, S. (2020). Birth prevalence of achondroplasia: a systematic literature review and meta-analysis. American Journal of Medical Genetics Part A, 182(10), 2297\u20132316. https:\/\/doi.org\/10.1002\/ajmg.a.61787","journal-title":"American Journal of Medical Genetics Part A"},{"key":"4251_CR2","unstructured":"National organization for rare disorders. Achondroplasia. Retrieved February 11 (2025), from https:\/\/rarediseases.org\/rare-diseases\/achondroplasia\/"},{"issue":"1","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1297\/cpe.2021-0043","volume":"31","author":"A Ajimi","year":"2022","unstructured":"Ajimi, A., Matsushita, M., Mishima, K., et al. (2022). Inconvenience and adaptation in Japanese adult achondroplasia and hypochondroplasia: a cross-sectional study. Clinical Pediatric Endocrinology, 31(1), 18\u201324. https:\/\/doi.org\/10.1297\/cpe.2021-0043","journal-title":"Clinical Pediatric Endocrinology"},{"issue":"3","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ajmg.a.62018","volume":"185","author":"EA Yonko","year":"2021","unstructured":"Yonko, E. A., Emanuel, J. S., Carter, E. M., & Raggio, C. L. (2021). Quality of life in adults with achondroplasia in the United States. American Journal of Medical Genetics Part A, 185(3), 695\u2013701. https:\/\/doi.org\/10.1002\/ajmg.a.62018","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"1","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ajmg.a.61903","volume":"185","author":"KM Pfeiffer","year":"2021","unstructured":"Pfeiffer, K. M., Brod, M., Smith, A., et al. (2021). Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia. American Journal of Medical Genetics Part A, 185(1), 33\u201345. https:\/\/doi.org\/10.1002\/ajmg.a.61903","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"1","key":"4251_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-022-02333-6","volume":"17","author":"NVJ Aldhouse","year":"2022","unstructured":"Aldhouse, N. V. J., Kitchen, H., Johnson, C., et al. (2022). Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials. Orphanet Journal of Rare Diseases, 17(1), 182. https:\/\/doi.org\/10.1186\/s13023-022-02333-6","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"1","key":"4251_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13023-021-01681-z","volume":"16","author":"PJ Ireland","year":"2021","unstructured":"Ireland, P. J., Savarirayan, R., Pocovi, T., et al. (2021). Development of the screening tool for everyday mobility and symptoms (STEMS) for skeletal dysplasia. Orphanet Journal of Rare Diseases, 16(1), 40. https:\/\/doi.org\/10.1186\/s13023-021-01681-z","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"4","key":"4251_CR8","doi-asserted-by":"publisher","first-page":"e1891","DOI":"10.1002\/mgg3.1891","volume":"10","author":"R Shediac","year":"2022","unstructured":"Shediac, R., Moshkovich, O., Gerould, H., et al. (2022). Experiences of children and adolescents living with achondroplasia and their caregivers. Molecular Genetics & Genomic Medicine, 10(4), e1891. https:\/\/doi.org\/10.1002\/mgg3.1891","journal-title":"Molecular Genetics & Genomic Medicine"},{"issue":"3","key":"4251_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3113\/JSOA.2015.0174","volume":"24","author":"V Landge","year":"2015","unstructured":"Landge, V., Shabtai, L., Gesheff, M., Specht, S. C., & Herzenberg, J. E. (2015). Patient satisfaction after limb lengthening with internal and external devices. Journal of Surgical Orthopaedic Advances, 24(3), 174\u2013179. https:\/\/doi.org\/10.3113\/JSOA.2015.0174","journal-title":"Journal of Surgical Orthopaedic Advances"},{"issue":"1","key":"4251_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13023-022-02372-z","volume":"17","author":"R Savarirayan","year":"2022","unstructured":"Savarirayan, R., Baratela, W., Butt, T., et al. (2022). Literature review and expert opinion on the impact of achondroplasia on medical complications and health-related quality of life and expectations for long-term impact of vosoritide: a modified Delphi study. Orphanet Journal of Rare Diseases, 17(1), 224. https:\/\/doi.org\/10.1186\/s13023-022-02372-z","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"2","key":"4251_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ajmg.a.31029","volume":"140","author":"WA Horton","year":"2006","unstructured":"Horton, W. A. (2006). Recent milestones in achondroplasia research. American Journal of Medical Genetics Part A, 140(2), 166\u2013169. https:\/\/doi.org\/10.1002\/ajmg.a.31029","journal-title":"American Journal of Medical Genetics Part A"},{"key":"4251_CR12","unstructured":"WorldHealth Organization. International classification of functioning, disability and health (ICF). Retrieved April 2 (2025), from https:\/\/icd.who.int\/dev11\/l-icf\/en\/"},{"issue":"2","key":"4251_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ajmg.a.62534","volume":"188","author":"KM Pfeiffer","year":"2022","unstructured":"Pfeiffer, K. M., Brod, M., Smith, A., Viuff, D., Ota, S., & Charlton, R. W. (2022). Functioning and well-being in older children and adolescents with achondroplasia: a qualitative study. American Journal of Medical Genetics Part A, 188(2), 454\u2013462. https:\/\/doi.org\/10.1002\/ajmg.a.62534","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"3","key":"4251_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41574-021-00595-x","volume":"18","author":"R Savarirayan","year":"2022","unstructured":"Savarirayan, R., Ireland, P., Irving, M., et al. (2022). International consensus statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia. Nature Reviews Endocrinology, 18(3), 173\u2013189. https:\/\/doi.org\/10.1038\/s41574-021-00595-x","journal-title":"Nature Reviews Endocrinology"},{"key":"4251_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/TACG.S51485","volume":"7","author":"PJ Ireland","year":"2014","unstructured":"Ireland, P. J., Pacey, V., Zankl, A., Edwards, P., Johnston, L. M., & Savarirayan, R. (2014). Optimal management of complications associated with achondroplasia. Applied Clinical Genetics, 7, 117\u2013125. https:\/\/doi.org\/10.2147\/TACG.S51485","journal-title":"Applied Clinical Genetics"},{"issue":"9","key":"4251_CR16","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1007\/s12325-023-02549-3","volume":"40","author":"MC Murton","year":"2023","unstructured":"Murton, M. C., Drane, E. L. A., Goff-Leggett, D. M., et al. (2023). Burden and treatment of achondroplasia: a systematic literature review. Advances in Therapy, 40(9), 3639\u20133680. https:\/\/doi.org\/10.1007\/s12325-023-02549-3","journal-title":"Advances in Therapy"},{"issue":"9","key":"4251_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1358\/dot.2022.58.9.3422313","volume":"58","author":"DM Paton","year":"2022","unstructured":"Paton, D. M. (2022). Efficacy of vosoritide in the treatment of achondroplasia. Drugs Of Today (Barcelona, Spain : 1998), 58(9), 451\u2013456. https:\/\/doi.org\/10.1358\/dot.2022.58.9.3422313","journal-title":"Drugs Of Today (Barcelona, Spain : 1998)"},{"issue":"1","key":"4251_CR18","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1017\/s0266462322000587","volume":"38","author":"KA Arntsen","year":"2022","unstructured":"Arntsen, K. A., Blount, L. G., Dickerson, B. J., Koola, C. P., Venable, Y., & Wildman, P. (2022). Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body. International Journal of Technology Assessment in Health Care, 38(1), e76. https:\/\/doi.org\/10.1017\/s0266462322000587","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"1","key":"4251_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s43441-023-00573-7","volume":"58","author":"N Bertelsen","year":"2024","unstructured":"Bertelsen, N., Dewulf, L., Ferr\u00e8, S., et al. (2024). Patient engagement and patient experience data in regulatory review and health technology assessment: a global landscape review. Therapeutic Innovation & Regulatory Science, 58(1), 63\u201378. https:\/\/doi.org\/10.1007\/s43441-023-00573-7","journal-title":"Therapeutic Innovation & Regulatory Science"},{"key":"4251_CR20","unstructured":"Eastern Research Group, Inc (2021). Assessment of the use of patient experience data in regulatory decision-making. U.S. Food and Drug Administration. Retrieved April 2, 2025, from https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/assessment-use-patient-experience-data-regulatory-decision-making"},{"issue":"1","key":"4251_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822x05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59\u201382. https:\/\/doi.org\/10.1177\/1525822x05279903","journal-title":"Field Methods"},{"issue":"9","key":"4251_CR22","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s11136-019-02210-z","volume":"28","author":"J Bloemeke","year":"2019","unstructured":"Bloemeke, J., Sommer, R., Witt, S., et al. (2019). Cross-cultural selection and validation of instruments to assess patient-reported outcomes in children and adolescents with achondroplasia. Quality of Life Research, 28(9), 2553\u20132563. https:\/\/doi.org\/10.1007\/s11136-019-02210-z","journal-title":"Quality of Life Research"},{"issue":"15","key":"4251_CR23","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1080\/09638288.2018.1447028","volume":"41","author":"J Bloemeke","year":"2019","unstructured":"Bloemeke, J., Sommer, R., Witt, S., et al. (2019). Piloting and psychometric properties of a patient-reported outcome instrument for young people with achondroplasia based on the International classification of functioning, disability and health: the Achondroplasia Personal Life Experience Scale (APLES). Disability and Rehabilitation, 41(15), 1815\u20131825. https:\/\/doi.org\/10.1080\/09638288.2018.1447028","journal-title":"Disability and Rehabilitation"},{"issue":"2","key":"4251_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/jllr.jllr_7_24","volume":"10","author":"I Ginebreda","year":"2024","unstructured":"Ginebreda, I., Ib\u00e1\u00f1ez, M., Canu, N., Echavarria, C., Lebre, J., & P\u00e9rez, M. (2024). Health-related quality of life in patients with achondroplasia after global limb-lengthening surgery: a case series. Journal of Limb Lengthening & Reconstruction, 10(2), 55\u201363. https:\/\/doi.org\/10.4103\/jllr.jllr_7_24","journal-title":"Journal of Limb Lengthening & Reconstruction"},{"issue":"4","key":"4251_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.dhjo.2013.04.003","volume":"6","author":"N Haga","year":"2013","unstructured":"Haga, N., Kosaki, K., Takikawa, K., et al. (2013). Education and related support from medical specialists for Japanese patients with major skeletal dysplasias. Disability and Health Journal, 6(4), 399\u2013404. https:\/\/doi.org\/10.1016\/j.dhjo.2013.04.003","journal-title":"Disability and Health Journal"},{"issue":"4","key":"4251_CR26","doi-asserted-by":"publisher","first-page":"103816","DOI":"10.1016\/j.ejmg.2019.103816","volume":"63","author":"H Lorne","year":"2020","unstructured":"Lorne, H., Newman, C. J., & Unger, S. (2020). Is height important for quality of life in children with skeletal dysplasias? European Journal of Medical Genetics, 63(4), 103816. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103816","journal-title":"European Journal of Medical Genetics"},{"issue":"24","key":"4251_CR27","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1080\/09638288.2016.1226969","volume":"39","author":"R Sommer","year":"2017","unstructured":"Sommer, R., Bl\u00f6meke, J., Dabs, M., Witt, S., Bullinger, M., & Quitmann, J. (2017). An ICF-CY-based approach to assessing self- and observer-reported functioning in young persons with achondroplasia: development of the pilot version of the Achondroplasia Personal Life Experience Scale (APLES). Disability and Rehabilitation, 39(24), 2499\u20132503. https:\/\/doi.org\/10.1080\/09638288.2016.1226969","journal-title":"Disability and Rehabilitation"},{"issue":"1","key":"4251_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13023-019-1171-9","volume":"14","author":"S Witt","year":"2019","unstructured":"Witt, S., Kolb, B., Bloemeke, J., Mohnike, K., Bullinger, M., & Quitmann, J. (2019). Quality of life of children with achondroplasia and their parents: a German cross-sectional study. Orphanet Journal of Rare Diseases, 14(1), 194. https:\/\/doi.org\/10.1186\/s13023-019-1171-9","journal-title":"Orphanet Journal of Rare Diseases"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04251-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:03:11Z","timestamp":1785312191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04251-7","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Salus Institutional Review Board on 20 January 2023 (#23007-01). This study was performed in accordance with the Declaration of Helsinki of 1964 and its later amendments. Before completing any study-related activities, participants provided informed consent to participate in the study. Participants under 18 years of age provided assent, and their caregiver provided informed consent. No investigational drugs, devices, or invasive procedures were administered or evaluated.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.M. was an employee of Sanofi at the time this study was conducted and may hold shares or stock options in the company. C.R., K.I.B., and S.B. are current employees of Sanofi and may hold shares or stock options in the company. G.S.F., K.C., and M.Q. are employees of Evidera PPD, Thermo Fisher Scientific, which received funds paid by Sanofi to Thermo Fisher Scientific for work relating to this study.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Some results were previously presented in a poster at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting, September 2024, Toronto, ON, Canada.","order":3,"name":"Ethics","label":"Prior presentations regarding this research","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"145"}}